Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|June 13, 2023
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agentsClaire Battin, Annika De Sousa Linhares, Judith Leitner, et al.
European Journal of Immunology|June 23, 2009
B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interactionJudith Leitner, Christoph Klauser, Winfried F Pickl, et al.
Glia|September 2, 2022
Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitroJakob Berner, Tamara Weiss, Helena Sorger, et al.
Bioorganic Chemistry|August 13, 2022
Design, synthesis and biological evaluation of PD-1 derived peptides as inhibitors of PD-1/PD-L1 complex formation for cancer therapyMagdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2015
Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4dJohannes Hofer, Florian Forster, David E Isenman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 9, 2010
Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactionsHans J Kueng, Calin Manta, Daniela Haiderer, et al.
Translational Oncology|February 15, 2024
Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancerMagdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, et al.
Frontiers in Molecular Medicine|August 1, 2024
Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptorsFarhana Jahan, Jan Koski, Diana Schenkwein, et al.
Developmental and Comparative Immunology|March 30, 2021
Expression of CD9 on porcine lymphocytes and its relation to T cell differentiation and cytokine productionJemma V Milburn, Anna M Hoog, Simona Winkler, et al.
Pageof 14